The top two positions in the S&P 500 gainers were eliminated due to pending mergers. Hospira Inc. (NYSE: HSP) was the top performing S&P 500 stock with a 43.5% gain so far this year, but Pfizer Inc. (NYSE: PFE) is acquiring Hospira for $90 per share.
Management will buy-back stock. The company has $2.00 per share in earnings now and in a year it will have $3 per share. A fifteen multiple (conservative given the business and competing investments) gives you $45. Hospira, Inc. (NYSE:HSP) is a ...
ValueWalk · 4y
This suggests that analysts have very recently bumped up their estimates for HSP, giving the stock a Zacks Earnings ESP of 5.66% heading into earnings season. Why is this Important? A positive reading for the Zacks Earnings ESP has proven to be very ...
Hospira shares closed at $29.81, down nearly 9 percent, on the New York Stock Exchange. The company said it expects the ban to hurt 2013 adjusted earnings by 5 cents to 15 cents per share. Hospira had forecast 2013 adjusted earnings of $2.05 to $2.20 per ...
HSP), to purchase all outstanding shares of the common stock of Javelin. As previously announced, the offer expired at 12:00 midnight, New York City time, on June 30, 2010 (the end of the day on June 30, 2010). Based on information provided by ...
Hospira Inc. (NYSE: HSP) Raised to Buy at BofA/ML ... Kindred Healthcare, Inc. (NYSE: KND) named as Value stock of the day at Zacks. Netflix, Inc. (NASDAQ: NFLX) Cut to Neutral at Citigroup (boy, how timely). Praxair Inc. (NYSE: PX) Cut to Underperform ...
The two largest US pharmacy benefit managers are combining forces: Express Scripts (ESRX) will buy Medco Health ... above its SMA200. The stock has had a couple of great days, gaining 10.73% over the last week. 8. Hospira Inc. (HSP): Drug Delivery Industry.
A lawsuit was filed by a current investor in HSP shares over alleged breaches of fiduciary duty ... and ultimately artificially inflated stock prices by withholding damaging information. The lawsuit by current long term investors against the directors ...
SBWire · 6y
Agenus intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of its common stock offered in the public ... heat shock protein (HSP)-based vaccines, and immune adjuvants. These programs are supported ...